Apellis Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of APLS for the last quarter is 199.69 M USD, and it's 15.88% higher compared to the previous quarter. The net income of Q2 24 is -37.66 M USD.